Compass Diversified (CODI) Q3 2025 earnings review
Compliance Regained, but Costs Crush the Bottom Line
Compass Diversified has finally caught up on its SEC filings, resolving a major regulatory overhang caused by the Lugano fraud. While the operating subsidiaries (excluding Lugano) showed resilience with Revenue up 3.5% to $472M, the consolidated P&L is ugly. Net Loss attributable to Holdings widened significantly to $74M (vs $36M a year ago), driven by a doubling of interest expense and corporate costs. While the core businesses like Altor and 5.11 are performing, the holding company's cost structure—burdened by restatement fees and debt—is currently consuming all operational gains.
🐂 Bull Case
By filing the Q3 10-Q and becoming current with the SEC, CODI removes the immediate threat of credit facility defaults and delisting. This was the primary overhang on the stock for the past year.
The Niche Industrial segment is Accelerating. Altor Solutions delivered a standout quarter with Adjusted EBITDA jumping 45% YoY to $14.8M, proving the underlying portfolio has value independent of the Lugano issues.
🐻 Bear Case
Interest expense more than doubled YoY to $66.7M in Q3. This single line item is now larger than the combined Adjusted EBITDA of the top three subsidiaries (5.11, BOA, Altor combined = ~$54M). The capital structure is currently unsustainable without asset sales.
Corporate expense spiked to $47.3M from $22.7M a year ago, likely due to legal and accounting fees related to the restatements. Until these one-time costs normalize, GAAP profitability is impossible.
⚖️ Verdict: 🔴
Bearish. The 'all clear' on filings is a relief, but the financials reveal a company under immense stress. Operational wins at Altor and 5.11 are completely overshadowed by a $67M quarterly interest bill and spiraling corporate expenses.
Key Themes
Interest Expense Crisis
The most alarming metric in the report is Net Interest Expense, which surged to $66.7M in Q3 2025 from $31.6M in Q3 2024. This reflects higher rates and the cost of debt amendments required during the filing delays. This expense run-rate (~$260M annualized) severely limits capital allocation flexibility.
Altor Solutions Breakout
Accelerating. While the Branded Consumer segment was mixed, the Niche Industrial segment found a hero in Altor Solutions. Sales jumped 53% YoY (to $79.8M) and EBITDA grew 45% YoY ($14.8M vs $10.3M). This validates the diversification strategy, as industrial strength offset weakness elsewhere.
Lugano Remains a Drag
Stable Negative. Despite excluding Lugano from guidance, its financials are consolidated and hurt the bottom line. Lugano posted an Adjusted EBITDA loss of $(9.9M) in Q3. While this is an improvement from the $(13.3M) loss in the prior year, it remains a cash-burning asset that complicates the valuation story.
5.11 Tactical Stability
Stable. 5.11 Tactical, often the flagship, delivered steady results with Revenue up 3% to $143M and EBITDA up 6% to $22.2M. In a volatile macro environment, this stability is a key anchor for the Branded Consumer segment.
Corporate Expense Doubling
Corporate Adjusted EBITDA was $(47.3M) in Q3 compared to $(22.7M) in the prior year. This >100% increase is likely driven by the forensic accounting and legal costs associated with the Lugano investigation and restatements. Investors must monitor if this recedes in Q4 now that filings are current.
Other KPIs
Decelerating significantly from $48.6M in 24Q3 (-38%). The drop is entirely attributable to the Corporate segment expense ballooning ($24.5M increase), which wiped out the gains from the operating subsidiaries.
Accelerating slightly (+3.5% YoY). Growth was driven by Altor (+53%) and modest gains in 5.11 and Sterno, offsetting a huge decline in Lugano sales (from $14M down to unreported due to exclusion, but implied weak contribution).
Stable vs Dec 31, 2024 ($59.7M). However, working capital is tight, with Accounts Receivable rising to $225M and Inventories hitting $602M. Liquidity management will be critical given the high interest burden.
Guidance
Stable. Management reiterated this range. Context: Through Q3 YTD, Subsidiary EBITDA (sum of positive subs excluding Lugano) is ~$257M. This implies Q4 EBITDA of ~$78M-$98M. For comparison, Q3 combined subsidiary EBITDA (excluding Lugano and Corporate) was ~$87M. The guidance suggests a steady finish to the year.
Key Questions
Interest Expense Runway
Net interest expense doubled to $66M this quarter. Is this the new run-rate given current debt structures, and what specific deleveraging levers (asset sales) are you prioritizing to address this?
Corporate Cost Normalization
Corporate expenses spiked to $47M in Q3 due to restatement efforts. Now that you are current with filings, what is the normalized quarterly corporate expense run-rate we should model for 2026?
Lugano Strategy
Lugano continues to post EBITDA losses ($9.9M in Q3). Beyond excluding it from guidance, what is the strategic timeline for divesting or shutting down this segment to stop the P&L bleeding?
Altor's Surge
Altor Solutions grew 53% YoY. How much of this was organic versus acquisition-driven (Lifoam impact), and is this performance sustainable into 2026?